Effects of WB-EMS in Ulcerative Colitis Patients
- Conditions
- Ulcerative Colitis
- Registration Number
- NCT02144129
- Lead Sponsor
- University of Erlangen-Nürnberg Medical School
- Brief Summary
The purpose of this study is to determine the effect of 12 weeks of WB-EMS either applicated passive in a supine resting position or active during slight movements compared with a non-training control group on body composition, muscle strength and QoL in patients with ulcerative colitis.
Our main hypothesis is that active WB-EMS application is significantly more favorable to address our primary endpoints compared with passive application.
Our secondary hypothesis is that passive WB-EMS application is significantly more favorable to address our primary endpoints compared with non-training control.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- ulcerative colitis
- ambulatory subjects
- variables that conflicts with WB-EMS application (e.g. cardiac pacemakers)
- absence of more than two weeks during the interventional period.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Lean Body Mass 12 weeks, baseline to 12 week follow-up Lean Body Mass (LBM) and Appendicular Skeletal Muscle Mass (ASMM) as assessed by Dual-Energy-x-Ray Absorptiometry (DXA)
Isokinetic muscle strength 12 weeks, baseline to 12 week follow-up Isokinetic muscle strength of the leg extensors and - flexors as assessed by a isokinetic leg strength
- Secondary Outcome Measures
Name Time Method Quality of Life (QoL) 12 weeks, baseline to 12 week follow-up QoL as assessed by inflammatory bowel disease questionnaire (IBDQ-D) and Depression Scores
Isometric muscle strength 12 weeks, baseline 12 week follow-up Isometric strength of the trunk flexors.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Medizinische Klinik 1, University of Erlangen-Nurnberg
🇩🇪Erlangen, Franconia, Germany
Medizinische Klinik 1, University of Erlangen-Nurnberg🇩🇪Erlangen, Franconia, Germany